'Vaccines will have to be cheaper and easier to produce as more enter market'
There's a new vaccine that's entering clinical trials in Brazil, Mexico, Thailand, and Vietnam, called NDV-HXP-S.
The vaccine is grabbing headlines for its molecular design that could make it more potent, far easier to produce, and more affordable.
Dr. Boffa says the NDV-HXP-S is one of the dozens of promising vaccines in the pipeline.
There are at least 184 Covid-19 vaccines in pre-clinical stages and another 100 jabs in the process of being tested, she tells CapeTalk.
Globally, only five vaccines have been approved and widely offered in various countries.
As more vaccines enter the market, manufacturers will have to improve the science, efficacy, and affordability of their products, Dr. Boffa adds.
We can only see better things to come as the science gets more exact.Dr Jody Boffa, Research Fellow - Centre for Rural Health at University of KwaZulu-Natal
The ones that we have will tend to get better and better... They are going to have to be equally as effective, they are going to have to work against the new variants of concern and they are going to gave to make them cheaper and easier to produce.Dr Jody Boffa, Research Fellow - Centre for Rural Health at University of KwaZulu-Natal
Once we get these vaccines into people's arms - and who knows how long that will take - we're not out of the woods yet. We still don't know how long that protection lasts... Are we going to have to be ordered these expensive Pfizer vaccines once a year or twice a year to boost people's immune systems?Dr Jody Boffa, Research Fellow - Centre for Rural Health at University of KwaZulu-Natal
If we could find something that we could make locally, and at a fraction of the cost, and that doesn't involve this complex cold chain to supply the doses and is potentially a single dose... That is indeed a game-changer.Dr Jody Boffa, Research Fellow - Centre for Rural Health at University of KwaZulu-Natal
Listen to the discussion on Afternoon Drive with John Maytham:
Source : https://www.123rf.com/photo_50038101_pharmaceutical-industry-production-line-machine-conveyor-with-glass-bottles-ampoules-at-factory-shal.html
He did manage to cover his privates with his cell phone, jokes Adam Gilchrist in The World View report.Read More
Is there a way to take some of the risks out of investing in cryptos? Yes, by building a balanced portfolio that helps spread some of the risks.Read More
What lessons can South Africans learn from the Madoff disaster? Bruce Whitfield interviews Vestact's Michael Treherne.Read More
South African documentary film 'My Octopus Teacher' has won a Bafta Award for Best Documentary.Read More
The United States has been at war in Afghanistan for 20 years – the longest of the many wars it has fought.Read More
'We've got a colour shoe for every ring of the Olympic Games!' The Money Show interviews Veldskoen CEO Nick Dreyer.Read More
Six cases of rare type of blood clotting have been reported out of a total of 6.8 million vaccinations with the J&J Covid-19 shot.Read More
Dr. Dirk Koekemoer is the brains behind a portable audiometer that is being used aboard the International Space Station (ISS).Read More
The conflict in Cabo Del Gado is not part of the global jihad, says Dr Joseph Hanlon. It is about people fighting for resources.Read More
A powerful stop-motion animation short film, produced by Humane Society International, raises awareness about the cruelty of animal testing.Read More